N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.39p
   
  • Change Today:
      0.006p
  • 52 Week High: 3.07
  • 52 Week Low: 0.35
  • Currency: UK Pounds
  • Shares Issued: 832.28m
  • Volume: 773,242
  • Market Cap: £3.28m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Nigel Theobald 12,389,919 £48,871
Luke Cairns 142,660 £563

Major Shareholders

Notifier** Holding Value*
TRACARTA LIMITED 150,000,000 £591,666
Northern Standard Limited 150,000,000 £591,666
Mathenz Marc Kay 74,000,000 £291,889
Patrick Byrne 43,162,500 £170,252
David Farrier 28,000,000 £110,444
Peel Hunt LLP 7,436,152 £29,332
MYLES MCNULTY 4,000,000 £15,778
Lynchwood Nominees Limited 690,800 £2,725
Barclays Stockbrokers Limited 447,800 £1,766
LR Nominees Limited 311,600 £1,229

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.39p
Change Today 0.006p
% Change -1.39 %
52 Week High 3.07
52 Week Low 0.35
Volume 773,242
Shares Issued 832.28m
Market Cap £3.28m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.35% below the market average53.35% below the market average53.35% below the market average53.35% below the market average53.35% below the market average
69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average
Value
53.35% below the market average53.35% below the market average53.35% below the market average53.35% below the market average53.35% below the market average
69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average
Income Not Available
Growth
23.34% above the market average23.34% above the market average23.34% above the market average23.34% above the market average23.34% above the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average

N4 Pharma Dividends

No dividends found

Trades for 20-Jun-2025

Time Volume / Share Price
11:30 6,472 @ 0.39p
09:13 703,070 @ 0.43p
09:00 62,500 @ 0.40p
09:00 12,500 @ 0.40p
09:00 50,000 @ 0.40p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page